CN Stock MarketDetailed Quotes

Shandong Keyuan Pharmaceutical (301281)

Watchlist
  • 39.35
  • -2.15-5.18%
Market Closed May 14 15:00 CST
4.26BMarket Cap181.34P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shandong Keyuan Pharmaceutical (301281) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
45.05%161.3M
-14.12%398.23M
-8.52%302.69M
-3.91%227.87M
-23.98%111.2M
3.60%463.72M
-2.88%330.88M
5.64%237.14M
17.75%146.28M
1.07%447.58M
Operating revenue
45.05%161.3M
-14.12%398.23M
-8.52%302.69M
-3.91%227.87M
-23.98%111.2M
3.60%463.72M
-2.88%330.88M
5.64%237.14M
17.75%146.28M
1.07%447.58M
Other operating revenue
----
-51.41%3.04M
----
375.83%3.08M
----
281.52%6.26M
----
102.86%646.97K
----
197.68%1.64M
Total operating cost
37.96%128.32M
-12.35%363.81M
-8.21%278.78M
-9.58%191.52M
-25.27%93.01M
8.93%415.07M
9.79%303.71M
22.49%211.81M
39.64%124.46M
9.52%381.06M
Operating cost
26.32%68.39M
-28.25%185.42M
-27.82%145.04M
-26.37%103.23M
-36.74%54.15M
9.46%258.43M
17.63%200.95M
31.97%140.21M
50.02%85.6M
-9.74%236.09M
Operating tax surcharges
3.09%1.61M
-25.38%4.84M
-31.48%3.8M
-38.56%2.77M
-0.04%1.57M
33.90%6.49M
48.88%5.54M
67.94%4.51M
11.55%1.57M
-8.63%4.84M
Operating expense
114.54%38.96M
4.48%80.61M
22.31%60.98M
26.37%43.99M
-13.24%18.16M
21.69%77.15M
9.76%49.86M
11.99%34.81M
45.21%20.93M
121.15%63.4M
Administration expense
30.63%13.44M
29.91%51.63M
25.10%34.97M
27.14%23.4M
20.93%10.29M
5.40%39.75M
-7.16%27.96M
-10.04%18.41M
-3.61%8.51M
33.96%37.71M
Financial expense
118.27%190.23K
59.04%-1.05M
48.91%-1.51M
44.16%-1.24M
-11.94%-1.04M
47.06%-2.57M
10.58%-2.95M
26.75%-2.22M
-35.84%-930.33K
-77.84%-4.85M
-Interest expense (Financial expense)
3,416.01%59.45K
-54.72%16.57K
--16.57K
--16.57K
--1.69K
--36.6K
----
----
----
----
-Interest Income (Financial expense)
65.92%-205.04K
66.50%-1.09M
67.26%-1.06M
65.89%-775.67K
52.86%-601.65K
13.47%-3.26M
-10.35%-3.24M
-23.84%-2.27M
---1.28M
-183.42%-3.77M
Research and development
-42.19%5.72M
18.23%42.35M
58.75%35.49M
20.35%19.36M
12.63%9.89M
-18.33%35.82M
-25.06%22.35M
4.03%16.08M
8.32%8.78M
62.64%43.86M
Credit Impairment Loss
-1,869.00%-3.62M
-39.72%-1.76M
-375.95%-634.26K
-315.93%-1.28M
112.01%204.65K
-994.84%-1.26M
134.84%229.85K
-165.49%-307.5K
-354.16%-1.7M
89.47%-115.01K
Asset Impairment Loss
224.26%385.4K
-130.65%-17.72M
-51.46%-5.4M
-213.15%-2.59M
-10,818.69%-310.17K
-127.45%-7.68M
-3,554.15%-3.57M
-746.98%-827.11K
88.05%-2.84K
-37.26%-3.38M
Other net revenue
-77.56%417.37K
-110.35%-2.03M
-77.89%4.11M
-83.78%2.78M
-28.78%1.86M
44.37%19.62M
143.95%18.61M
458.02%17.13M
472.12%2.61M
319.53%13.59M
Fair value change income
----
----
-54.04%348K
-86.23%50.96K
-91.11%90.41K
46.36%795K
-82.10%757.13K
-14.45%370.11K
--1.02M
--543.18K
Invest income
-6.87%600K
-51.20%5.93M
-41.16%4.27M
-35.38%3.74M
19.15%644.28K
-0.48%12.14M
332.96%7.25M
1,557.98%5.78M
--540.74K
--12.2M
-Including: Investment income associates
--600K
-70.52%2.1M
-51.51%2.05M
-43.26%2.05M
----
131.53%7.13M
--4.22M
--3.61M
----
--3.08M
Asset deal income
----
289.50%303.64K
108.48%162.52K
----
----
-77.47%77.96K
578.90%77.96K
578.90%77.96K
----
-9.16%345.99K
Other revenue
148.06%3.05M
-27.85%11.22M
-61.22%5.38M
-76.23%2.86M
-55.41%1.23M
289.38%15.54M
461.46%13.86M
531.77%12.04M
222.65%2.76M
-37.73%3.99M
Operating profit
66.59%33.4M
-52.56%32.39M
-38.79%28.02M
-7.86%39.13M
-17.92%20.05M
-14.80%68.26M
-36.14%45.78M
-22.27%42.47M
-31.29%24.43M
-18.39%80.12M
Add:Non operating Income
-98.20%71.81K
1,537.07%1.18M
8,576.46%5.12M
8,563.77%5.11M
--4M
-76.94%72.26K
-74.83%59.03K
-57.33%59.03K
----
8.13%313.37K
Less:Non operating expense
93.83%779.97K
539.34%16.79M
-58.91%1.2M
-73.34%476.91K
-66.45%402.4K
277.95%2.63M
404.10%2.92M
533.01%1.79M
2,102.48%1.2M
331.80%694.89K
Total profit
38.25%32.69M
-74.47%16.78M
-25.57%31.94M
7.43%43.77M
1.80%23.65M
-17.59%65.71M
-39.84%42.92M
-25.23%40.74M
-34.82%23.23M
-18.89%79.74M
Less:Income tax cost
271.79%2.16M
-92.61%401.65K
-79.66%683.62K
-76.16%1.12M
-65.98%580.06K
101.68%5.44M
-29.79%3.36M
43.47%4.71M
-51.97%1.71M
-61.61%2.7M
Net profit
32.38%30.54M
-72.83%16.38M
-20.97%31.26M
18.36%42.64M
7.17%23.07M
-21.76%60.27M
-40.57%39.56M
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
Net profit from continuing operation
32.38%30.54M
-72.83%16.38M
-20.97%31.26M
18.36%42.64M
7.17%23.07M
-21.76%60.27M
-40.57%39.56M
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
Less:Minority Profit
2,788.24%462.65K
0.23%-176.44K
-64.27%-209.63K
35.73%-41.08K
---17.21K
---176.85K
---127.62K
---63.92K
----
----
Net profit of parent company owners
30.27%30.07M
-72.62%16.55M
-20.69%31.47M
18.26%42.68M
7.25%23.08M
-21.54%60.45M
-40.38%39.68M
-29.52%36.09M
-32.92%21.52M
-15.60%77.04M
Earning per share
Basic earning per share
30.25%0.2777
-73.21%0.15
-20.71%0.2906
18.27%0.3942
7.24%0.2132
-26.32%0.56
-45.34%0.3665
-38.32%0.3333
-64.07%0.1988
-32.14%0.76
Diluted earning per share
30.25%0.2777
-73.21%0.15
-20.71%0.2906
18.27%0.3942
7.24%0.2132
-26.32%0.56
-45.34%0.3665
-38.32%0.3333
-64.07%0.1988
-32.14%0.76
Other composite income
Total composite income
32.38%30.54M
-72.83%16.38M
-20.97%31.26M
18.36%42.64M
7.17%23.07M
-21.76%60.27M
-40.57%39.56M
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
Total composite income of parent company owners
30.27%30.07M
-72.62%16.55M
-20.69%31.47M
18.26%42.68M
7.25%23.08M
-21.54%60.45M
-40.38%39.68M
-29.52%36.09M
-32.92%21.52M
-15.60%77.04M
Total composite income of minority owners
2,788.24%462.65K
0.23%-176.44K
-64.27%-209.63K
35.73%-41.08K
---17.21K
---176.85K
---127.62K
---63.92K
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Accounting Firm for the Meeting (Special General Partnership)
--
--
--
Accounting Firm for the Meeting (Special General Partnership)
--
--
--
ShinWing Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 45.05%161.3M-14.12%398.23M-8.52%302.69M-3.91%227.87M-23.98%111.2M3.60%463.72M-2.88%330.88M5.64%237.14M17.75%146.28M1.07%447.58M
Operating revenue 45.05%161.3M-14.12%398.23M-8.52%302.69M-3.91%227.87M-23.98%111.2M3.60%463.72M-2.88%330.88M5.64%237.14M17.75%146.28M1.07%447.58M
Other operating revenue -----51.41%3.04M----375.83%3.08M----281.52%6.26M----102.86%646.97K----197.68%1.64M
Total operating cost 37.96%128.32M-12.35%363.81M-8.21%278.78M-9.58%191.52M-25.27%93.01M8.93%415.07M9.79%303.71M22.49%211.81M39.64%124.46M9.52%381.06M
Operating cost 26.32%68.39M-28.25%185.42M-27.82%145.04M-26.37%103.23M-36.74%54.15M9.46%258.43M17.63%200.95M31.97%140.21M50.02%85.6M-9.74%236.09M
Operating tax surcharges 3.09%1.61M-25.38%4.84M-31.48%3.8M-38.56%2.77M-0.04%1.57M33.90%6.49M48.88%5.54M67.94%4.51M11.55%1.57M-8.63%4.84M
Operating expense 114.54%38.96M4.48%80.61M22.31%60.98M26.37%43.99M-13.24%18.16M21.69%77.15M9.76%49.86M11.99%34.81M45.21%20.93M121.15%63.4M
Administration expense 30.63%13.44M29.91%51.63M25.10%34.97M27.14%23.4M20.93%10.29M5.40%39.75M-7.16%27.96M-10.04%18.41M-3.61%8.51M33.96%37.71M
Financial expense 118.27%190.23K59.04%-1.05M48.91%-1.51M44.16%-1.24M-11.94%-1.04M47.06%-2.57M10.58%-2.95M26.75%-2.22M-35.84%-930.33K-77.84%-4.85M
-Interest expense (Financial expense) 3,416.01%59.45K-54.72%16.57K--16.57K--16.57K--1.69K--36.6K----------------
-Interest Income (Financial expense) 65.92%-205.04K66.50%-1.09M67.26%-1.06M65.89%-775.67K52.86%-601.65K13.47%-3.26M-10.35%-3.24M-23.84%-2.27M---1.28M-183.42%-3.77M
Research and development -42.19%5.72M18.23%42.35M58.75%35.49M20.35%19.36M12.63%9.89M-18.33%35.82M-25.06%22.35M4.03%16.08M8.32%8.78M62.64%43.86M
Credit Impairment Loss -1,869.00%-3.62M-39.72%-1.76M-375.95%-634.26K-315.93%-1.28M112.01%204.65K-994.84%-1.26M134.84%229.85K-165.49%-307.5K-354.16%-1.7M89.47%-115.01K
Asset Impairment Loss 224.26%385.4K-130.65%-17.72M-51.46%-5.4M-213.15%-2.59M-10,818.69%-310.17K-127.45%-7.68M-3,554.15%-3.57M-746.98%-827.11K88.05%-2.84K-37.26%-3.38M
Other net revenue -77.56%417.37K-110.35%-2.03M-77.89%4.11M-83.78%2.78M-28.78%1.86M44.37%19.62M143.95%18.61M458.02%17.13M472.12%2.61M319.53%13.59M
Fair value change income ---------54.04%348K-86.23%50.96K-91.11%90.41K46.36%795K-82.10%757.13K-14.45%370.11K--1.02M--543.18K
Invest income -6.87%600K-51.20%5.93M-41.16%4.27M-35.38%3.74M19.15%644.28K-0.48%12.14M332.96%7.25M1,557.98%5.78M--540.74K--12.2M
-Including: Investment income associates --600K-70.52%2.1M-51.51%2.05M-43.26%2.05M----131.53%7.13M--4.22M--3.61M------3.08M
Asset deal income ----289.50%303.64K108.48%162.52K---------77.47%77.96K578.90%77.96K578.90%77.96K-----9.16%345.99K
Other revenue 148.06%3.05M-27.85%11.22M-61.22%5.38M-76.23%2.86M-55.41%1.23M289.38%15.54M461.46%13.86M531.77%12.04M222.65%2.76M-37.73%3.99M
Operating profit 66.59%33.4M-52.56%32.39M-38.79%28.02M-7.86%39.13M-17.92%20.05M-14.80%68.26M-36.14%45.78M-22.27%42.47M-31.29%24.43M-18.39%80.12M
Add:Non operating Income -98.20%71.81K1,537.07%1.18M8,576.46%5.12M8,563.77%5.11M--4M-76.94%72.26K-74.83%59.03K-57.33%59.03K----8.13%313.37K
Less:Non operating expense 93.83%779.97K539.34%16.79M-58.91%1.2M-73.34%476.91K-66.45%402.4K277.95%2.63M404.10%2.92M533.01%1.79M2,102.48%1.2M331.80%694.89K
Total profit 38.25%32.69M-74.47%16.78M-25.57%31.94M7.43%43.77M1.80%23.65M-17.59%65.71M-39.84%42.92M-25.23%40.74M-34.82%23.23M-18.89%79.74M
Less:Income tax cost 271.79%2.16M-92.61%401.65K-79.66%683.62K-76.16%1.12M-65.98%580.06K101.68%5.44M-29.79%3.36M43.47%4.71M-51.97%1.71M-61.61%2.7M
Net profit 32.38%30.54M-72.83%16.38M-20.97%31.26M18.36%42.64M7.17%23.07M-21.76%60.27M-40.57%39.56M-29.64%36.03M-32.92%21.52M-15.60%77.04M
Net profit from continuing operation 32.38%30.54M-72.83%16.38M-20.97%31.26M18.36%42.64M7.17%23.07M-21.76%60.27M-40.57%39.56M-29.64%36.03M-32.92%21.52M-15.60%77.04M
Less:Minority Profit 2,788.24%462.65K0.23%-176.44K-64.27%-209.63K35.73%-41.08K---17.21K---176.85K---127.62K---63.92K--------
Net profit of parent company owners 30.27%30.07M-72.62%16.55M-20.69%31.47M18.26%42.68M7.25%23.08M-21.54%60.45M-40.38%39.68M-29.52%36.09M-32.92%21.52M-15.60%77.04M
Earning per share
Basic earning per share 30.25%0.2777-73.21%0.15-20.71%0.290618.27%0.39427.24%0.2132-26.32%0.56-45.34%0.3665-38.32%0.3333-64.07%0.1988-32.14%0.76
Diluted earning per share 30.25%0.2777-73.21%0.15-20.71%0.290618.27%0.39427.24%0.2132-26.32%0.56-45.34%0.3665-38.32%0.3333-64.07%0.1988-32.14%0.76
Other composite income
Total composite income 32.38%30.54M-72.83%16.38M-20.97%31.26M18.36%42.64M7.17%23.07M-21.76%60.27M-40.57%39.56M-29.64%36.03M-32.92%21.52M-15.60%77.04M
Total composite income of parent company owners 30.27%30.07M-72.62%16.55M-20.69%31.47M18.26%42.68M7.25%23.08M-21.54%60.45M-40.38%39.68M-29.52%36.09M-32.92%21.52M-15.60%77.04M
Total composite income of minority owners 2,788.24%462.65K0.23%-176.44K-64.27%-209.63K35.73%-41.08K---17.21K---176.85K---127.62K---63.92K--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Accounting Firm for the Meeting (Special General Partnership)------Accounting Firm for the Meeting (Special General Partnership)------ShinWing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.21%
Sample Name
Sample Code
 +1.57%
4
SINOPEC CORP
00386
+0.66%
5
CNOOC
00883
+0.53%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.24%
Sample Name
Sample Code
 +30.17%
4
Loongson Technology Corporation
688047
+19.58%
5
Digital China Group
000034
+16.92%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -